Status:
UNKNOWN
Getting Global Rare Disease Insights Through Technology Study
Lead Sponsor:
M.A.G.I.C. Clinic LTD
Collaborating Sponsors:
Hanalytics Solutions Inc.
Conditions:
Metabolic Disease
Fabry Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This project is a randomized controlled trial to use a mobile health journal, called Zamplo (formerly known as MyHealthJournal or ZoeInsights), to record patient reported outcomes (PROM) in patients w...
Eligibility Criteria
Inclusion
- Adult patients with a diagnosis of metabolic disease
- Access to a smartphone/computer with data connection
- Willingness to devote 10-15 mins of time in a day to log medications and notes
- Able to speak and write English sufficiently to complete questionnaires
Exclusion
- Insufficient cognitive function to participate in the study
- The use of any electronic application requires some competency with the software on a cellphone, downloading the application and entering the data. Some patients who are elderly may not be familiar with this technology and would be excluded.
Key Trial Info
Start Date :
August 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04758130
Start Date
August 7 2020
End Date
November 30 2021
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M.A.G.I.C. Clinic LTD
Calgary, Alberta, Canada, T2M0L6